Not applicableStudy completedNCT05572450What this trial is testingDose, Safety, and Pathogenicity of a New Influenza H1N1 Challenge StrainWho this might be right forInfluenza A H1N1 Hvivo 70
Early research (Phase 1)Study completedNCT00973895What this trial is testingVRC 308: An Open-Label Phase I Study of the Safety and Immunogenicity of an Investigational H1 DNA Influenza Vaccine, VRC-FLUDNA057-00-VP, in Healthy Adults 18-70 Years OldWho this might be right forInfluenza A Virus, H1N1 SubtypeNovel Swine-Origin National Institute of Allergy and Infectious Diseases (NIAID) 20
Large-scale testing (Phase 3)Study completedNCT00970177What this trial is testingImmunogenicity, Safety and Tolerability of Two Doses of Adjuvanted and Non-adjuvanted Swine Origin A/H1N1 Monovalent Influenza Vaccine in Healthy Subjects 18 or More Years of AgeWho this might be right forPandemic Influenza Novartis Vaccines 812
Not applicableStudy completedNCT01011582What this trial is testingCharacteristics and Outcomes of Intensive Care Unit Patients Admitted With Novel H1N1 Influenza or Seasonal InfluenzaWho this might be right forH1N1 InfluenzaSeasonal Influenza Virginia Commonwealth University 4
Post-approval studies (Phase 4)UnknownNCT00936013What this trial is testingChinese Medicinal Herbs Treatment on Novel Influenza A (H1N1)Pneumonia: Multi-centre, Prospective, Randomized Controlled StudyWho this might be right forInfluenza Capital Medical University 400
Not applicableStudy completedNCT01289418What this trial is testingSurveillance for Adverse Events Following Pandemic H1N1 ImmunizationWho this might be right forNovel Influenza A/H1N1 PHAC/CIHR Influenza Research Network 6,525
Large-scale testing (Phase 3)Study completedNCT01031719What this trial is testingClinical Trial to Compare the Immunogenicity, Safety, and Tolerability of an Adjuvanted A(H1N1) Influenza Vaccine Versus Non-Adjuvanted A(H1N1) Influenza Vaccines in Patients With Invasive Solid TumorsWho this might be right forH1N1 Influenza VirusInvasive Solid Tumors Chiltern Pesquisa Clinica Ltda 59
Large-scale testing (Phase 3)Study completedNCT01032395What this trial is testingImmunogenicity, Safety, and Tolerability of an MF59-Adjuvanted Versus Non-Adjuvanted Influenza Vaccines in Patients With Chronic Pulmonary Disease, Chronic Heart Disease, or Diabetes MellitusWho this might be right forH1N1 Influenza VirusChronic Pulmonary DiseaseChronic Heart Disease+1 more Chiltern Pesquisa Clinica Ltda 342
Not applicableUnknownNCT01046227What this trial is testingAntibody Titer Analysis After H1N1 Vaccination in Pediatric Haemato-oncology PatientsWho this might be right forSerology AnalysisNovel H1N1 Influenza VaccinationPediatric Haemato-oncology Patients National Taiwan University Hospital 50
Not applicableStudy completedNCT01046734What this trial is testingVirus Shedding and Environmental Deposition of a Novel Influenza VirusWho this might be right forNovel (H1N1) Influenza University of Nottingham 105
Not applicableStudy completedNCT05797103What this trial is testingThe Research of Novel Electrolyzed Water Spray to Eradicate Bacteria E-coli and an Attenuated Human Flu VirusWho this might be right forBacterial GrowthNovel Influenza A (H1N1) Dove Medical Press Ltd 20
Not applicableStudy completedNCT01056354What this trial is testingRespiratory Virus Outpatient Study (FLU 002 Plus)Who this might be right forInfluenza and Other Novel Respiratory Viruses University of Minnesota 11,719
Large-scale testing (Phase 3)Study completedNCT01000207What this trial is testingSingle-blind, Dose-ranging Study of Novel Swine Influenza Virus Vaccine in Japanese Pediatric SubjectsWho this might be right forSwine-Origin Influenza A H1N1 Virus Novartis Vaccines 123
Not applicableStudy completedNCT01056185What this trial is testingRespiratory Virus Hospitalization Study (FLU 003 Plus)Who this might be right forInfluenzaNovel Respiratory Virus-1 Middle Eastern Respiratory Syndrome Coronavirus (MERS-CoV)Novel Respiratory Virus-2 Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) University of Minnesota 1,000
Early research (Phase 1)Study completedNCT01855945What this trial is testingSafety and Immunogenicity of Three Dosage Levels of Swine Influenza Vaccine in Children Ages 3 to <9 Years, Adolescents 9 to <18 Years, Adults 18 to <65 Years and Elderly 65 Years and Older.Who this might be right forProphylaxis of A/H3N2v Influenza Novartis Vaccines 627
Large-scale testing (Phase 3)Study completedNCT00972816What this trial is testingSafety and Immunogenicity of A/H1N1-SOIV (Swine Flu) Vaccine With and Without Adjuvant in Children (3 to < 9 Years)Who this might be right forInfluenza Novartis Vaccines 1,357
Large-scale testing (Phase 3)Study completedNCT00971542What this trial is testingImmunogenicity, Safety and Tolerability of Two Doses of Adjuvanted and Non-adjuvanted Swine Origin A/H1N1 Monovalent Influenza Vaccine (Egg-Derived) in Healthy Subjects From 6 Months to 17 Years of AgeWho this might be right forPandemic Influenza Novartis Vaccines 778
Not applicableStudy completedNCT01192958What this trial is testingValidate a New Oral Fluid/Saliva Antibody Test for Novel H1N1v InfluenzaWho this might be right forH1N1 Virus Public Health England
Not applicableStudy completedNCT01023711What this trial is testingImmunologic Response to Inactivated Vaccine for Novel H1N1 VirusWho this might be right forInfluenza University of Rochester 107
Post-approval studies (Phase 4)Study completedNCT00956111What this trial is testingA Clinical Trial With Influenza A/H1N1 VaccinesWho this might be right forInfluenza Sinovac Biotech Co., Ltd 1,614